[1]
“Beyond glycemic control: The role of Tirzepatide in MASLD and OSA management”, J. Assoc. Clin. Endocrinol. Diabetol. Bangladesh, vol. 4, no. 20, p. S29, Oct. 2025, doi: 10.3329/jacedb.v4i20.84905.